| Alexion Pharmaceutical CEO Discusses Q3 2011 Results - Earnings Call Transcript - Seeking Alpha |
|
|
Seeking Alpha In these early stages of our aHUS introduction, we recognize that there is already substantial interest in the area of complement activation across the broader nephrology community. In this regard, we are pleased to note that more than 50 abstracts ... Deutsche Bank (DB) Analysts Reiterate a "Buy" Rating on Alexion |